Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by BARON RICHARD A, Director. Officer active across 1 company, notably Immunome Inc.. Cumulatively, 2 filings have been recorded. Activity tracked since 18 August 2021. The latest transaction was filed on 18 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Richard A. Baron is a Board Member at Immunome Inc., a company focused on developing immunological therapies. As a board member, he plays a key role in overseeing operations and guiding the company's strategic direction. His expertise in biotechnology is valuable in supporting Immunome's efforts to innovate and meet patient needs.